- Our Services
- Eye Conditions
- Cosmetic Procedures
- Meet Our Doctors
- Contact Us
There are many new intraocular treatments available at Ohio Eye Alliance. An intraocular injection allows medication to be absorbed directly into the eye, maximizing its effectiveness.
In each injection, the eye is numbed, either through topical anesthesia or with a small dose of anesthetic injected under the conjunctiva, the surface layer of the eye. Aseptic techniques are always employed to minimize any risk of infection.
After injection, it is common for patients to experience “floaters,” in their vision, as the medication moves inside the eye. This gradually lessens and resolves as the medication is absorbed into the eye. This process takes 2-3 days.
*Click the links below to find out more Information.
Ophthalmologists are using Avastin “off-label” to treat AMD and similar conditions since reasearch indicates that VEGF is one of the causes
for the growth of the abnormal vessls that cause theese conditions. Some patients treated with Avastin had less fluid amd more normal-appearing
maculas, and their vision improved. Avastin is also used, therefore, to treat macular edema, or swelling of the macula.
Your ophthalmologist may treat your wet AMD or other disease of the retina with a drug called anti-VEGF. Anti-VEGF treatment improves vision in about one third (1 out of 3) people who take it. For a vast majority (9 out of 10), it at least
Vascular endothelial growth factor (VEGF) is a protein produced by cells in your body. VEGF causes leaky blood vessels and stimulates formation of new blood vessels.
Sometimes cells can produce too much VEGF. When this happens blood vessels become leaky and fluid can accumulate in the vision center. New blood vessels can form in the vision center as well. This can lead to low vision or blindness.
Anti-VEGF medicine blocks VEGF, reducing fluid from accumulating in the vision center and slowing the growth of blood vessels in the eye. This slows or stops damage and slows down vision loss. Sometimes it can even improve vision.
Ophthalmologists use anti-VEGF medicines to treat the following eye problems:
Ophthalmologists generally consider all three to be safe and effective treatments for retinal disease. One study that compared the effectiveness of Lucentis and Avastin found them both effective for treating Wet AMD. The differences among Avastin, Lucentis and Eylea have to do with cost and packaging. Risk factors are similar in all three medications. A number of new anti-VEGF drugs are nearing approval and patients may have more treatment options in coming years.
This is what you can expect during treatment:
Your ophthalmologist will decide how many treatments you need. You may need other types of treatment along with anti-VEGF treatments.
It can treat multiple conditions
Lucentis is the brand name for the drug, which is called ranibizumab. It blocks the growth of abnormal blood vessels in the back of the eye.
Those blood vessels can leak and affect vision, causing vision loss.
Eylea is the brand name for the drug, which is called aflibercept. It blocks the growth of abnormal blood vessels in the back of the
eye. Those blood vessels can leak and affect vision, causing vision loss. It is approved for up to 8 weeks extended treatment.